CA SB 1012

Title: The Regulated Psychedelic Facilitators Act and the Regulated Psychedelic-Assisted Therapy Act.
Author: Marie Waldron

SB 1012, as amended, Wiener. The Regulated Psychedelic Facilitators Act and the Regulated Psychedelic-Assisted Therapy Act. (1) Existing law provides for the regulation of various professions and vocations by boards established under the jurisdiction of the Department of Consumer Affairs in the Business, Consumer Services, and Housing Agency. Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 schedules, and places the greatest restrictions and penalties on the use of those substances placed in Schedule I. Existing law classifies dimethyltryptamine, mescaline, 3,4-methylenedioxymethamphetamine (MDMA), ibogaine, psilocybin, and psilocyn as Schedule I substances, and prohibits various actions related to those substances, including their sale, possession, transportation, manufacture, or cultivation.(2) This bill would enact the Regulated Psychedelic Facilitators Act, which would establish the Board of Regulated Psychedelic Facilitators in the Department of Consumer Affairs to license and regulate psychedelic facilitators, as defined. The bill would require the board to be appointed, as specified, by April 1, 2025. The bill would require the board to establish educational, training, and other qualifications and requirements for obtaining a license as a regulated psychedelic facilitator and would establish conditions of licensure. The bill would require the board to establish fees for the reasonable regulatory costs to the board to administer the act. The bill would require the board to begin accepting license applications by April 1, 2026. The bill would make a license subject to renewal every 2 years. The bill would create the Regulated Psychedelic Facilitators Fund in the State Treasury, would require all funds received pursuant to the act to be credited to the fund, and would make moneys in the fund available to the board for the act’s purposes upon appropriation by the Legislature. The bill would require the board, consistent with recommendations made by the Regulated Psychedelic Substances Advisory Committee, which would be created by the bill, to adopt regulations, on or before January 1, 2026, governing the safe provision of regulated psychedelic facilitation, including regulations governing the scope of practice for regulated psychedelic facilitators and recordkeeping requirements, provided the recordkeeping does not result in the disclosure of personally identifiable information of participants. The bill would require the board to determine which schools and programs meet the requirements of the act and to adopt regulations governing the requirements and process for approving schools and programs related to the provision of psychedelic facilitation training. The bill would authorize the board to charge a reasonable fee for the inspection or approval of schools or programs. The bill would make a violation of the act a misdemeanor and subject a licenseholder’s license to suspension or revocation. The bill would make a violation of specified acts subject to discipline or denial of a license by the board in accordance with specified procedures. By creating a new crime, the bill would impose a state-mandated local program. The bill would make specified practices unfair business practices, including a person without a license holding themselves out as a regulated psychedelic facilitator. The bill would authorize a local government to reasonably regulate the time, place, and manner of regulated psychedelic facilitation within its boundaries.(3) This bill would enact the Regulated Psychedelic-Assisted Therapy Act to establish a comprehensive system to control and regulate the production, distribution, transportation, storage, processing, manufacturing, testing, quality control, and sale of regulated psychedelic substances for use in conjunction with psychedelic facilitation, as defined, the provision of psychedelic facilitation, the approval of locations where regulated psychede

May 16 hearing: Held in committee and under submission.

Bill Documents
CA SB 1012 - 03/20/24 - Amended Senate
03/20/24 - CA SB 1012 (03/20/24 - Amended Senate)

CA SB 1012 - 02/05/24 - Introduced
02/05/24 - CA SB 1012 (02/05/24 - Introduced)

Add To Favorites

Author Details

  • Marie Waldron - R
    Assemblywoman - State Assembly - CA

    Contact this Assemblywoman
    Visit their Website

    Contact Tips

    Capital Address:
    P.O. Box 942849, 1021 O Street, Suite 6140
    Sacramento, CA 94249-0075

    District Address:
    9820 Willow Creek Rd Ste 240
    San Diego, CA 92131 1114
    Phone: 8585667538